Screener
Rapport Therapeutics, Inc. RAPP PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Restricted cash | 105 | 105 |
| Prepaid expenses and other current assets | 10,381 | 7,917 |
| Total current assets | 446,856 | 498,561 |
| Property and equipment, net | 2,337 | 2,976 |
| Operating lease right of use asset, net | 8,732 | 9,909 |
| Other assets | 1,057 | 985 |
| Total assets | $458,982 | $512,431 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s PP&E (net)?
- Rapport Therapeutics, Inc. (RAPP) reported PP&E (net) of $2.34M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Rapport Therapeutics, Inc.'s PP&E (net) decreased by 26.3% year-over-year, from $3.17M to $2.34M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s PP&E (net)?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s PP&E (net) has grown at a 24.6% compound annual growth rate (CAGR), from $1.92M to $2.98M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Rapport Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude